Insulin Pump Market Will Expand With MEMS Technology – Animas

Animas aims to introduce a next-generation insulin micro-pump to the U.S. in 2007, having acquired rights to Debiotech's micro-electromechanical systems (MEMS) technology

More from Archive

More from Medtech Insight